Deutsche Bank AG lifted its position in shares of Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 37.0% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 415,391 shares of the construction company's stock after purchasing an additional 112,241 shares during the quarter. Deutsche Bank AG owned about 0.51% of Aspen Aerogels worth $4,935,000 as of its most recent filing with the SEC.
A number of other institutional investors have also modified their holdings of ASPN. Alyeska Investment Group L.P. purchased a new stake in shares of Aspen Aerogels during the 4th quarter worth about $9,504,000. Dendur Capital LP purchased a new position in Aspen Aerogels in the 4th quarter worth approximately $9,207,000. Renaissance Technologies LLC boosted its holdings in Aspen Aerogels by 472.4% in the 4th quarter. Renaissance Technologies LLC now owns 766,400 shares of the construction company's stock worth $9,105,000 after acquiring an additional 632,500 shares during the period. Prescott Group Capital Management L.L.C. purchased a new position in Aspen Aerogels in the 4th quarter worth approximately $5,126,000. Finally, Dimensional Fund Advisors LP boosted its holdings in Aspen Aerogels by 25.5% in the 4th quarter. Dimensional Fund Advisors LP now owns 2,018,631 shares of the construction company's stock worth $23,983,000 after acquiring an additional 409,862 shares during the period. Hedge funds and other institutional investors own 97.64% of the company's stock.
Aspen Aerogels Stock Up 5.6%
Shares of Aspen Aerogels stock traded up $0.34 on Thursday, hitting $6.43. 1,885,136 shares of the company's stock traded hands, compared to its average volume of 1,980,455. The stock has a market cap of $527.94 million, a P/E ratio of 40.19 and a beta of 2.72. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. The firm's 50-day moving average is $5.83 and its 200 day moving average is $9.89. Aspen Aerogels, Inc. has a 52-week low of $4.16 and a 52-week high of $33.15.
Aspen Aerogels (NYSE:ASPN - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The construction company reported ($0.06) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.07) by $0.01. The business had revenue of $78.72 million for the quarter, compared to analyst estimates of $82.75 million. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. The business's revenue was down 16.7% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.02) EPS. Equities analysts anticipate that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current year.
Wall Street Analyst Weigh In
A number of equities analysts have weighed in on ASPN shares. TD Cowen upgraded Aspen Aerogels to a "strong-buy" rating in a report on Tuesday, March 11th. Roth Mkm decreased their price target on Aspen Aerogels from $22.00 to $16.00 and set a "buy" rating for the company in a report on Friday, February 14th. Canaccord Genuity Group decreased their price target on Aspen Aerogels from $20.00 to $15.00 and set a "buy" rating for the company in a report on Friday, February 14th. Wall Street Zen upgraded Aspen Aerogels to a "sell" rating in a report on Wednesday, February 19th. Finally, Oppenheimer cut Aspen Aerogels from an "outperform" rating to a "market perform" rating in a report on Thursday, May 8th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $19.11.
Check Out Our Latest Report on ASPN
Insider Activity at Aspen Aerogels
In other news, CEO Donald R. Young purchased 20,000 shares of the company's stock in a transaction that occurred on Monday, May 12th. The shares were acquired at an average cost of $5.35 per share, with a total value of $107,000.00. Following the transaction, the chief executive officer now owns 550,856 shares in the company, valued at approximately $2,947,079.60. The trade was a 3.77% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 4.30% of the company's stock.
About Aspen Aerogels
(
Free Report)
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Featured Articles

Before you consider Aspen Aerogels, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.
While Aspen Aerogels currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.